80 related articles for article (PubMed ID: 9796551)
21. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
Nikodemski T
Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
[TBL] [Abstract][Full Text] [Related]
22. Role of the infectious diseases specialist consultant on the appropriateness of antimicrobial therapy prescription in an intensive care unit.
Raineri E; Pan A; Mondello P; Acquarolo A; Candiani A; Crema L
Am J Infect Control; 2008 May; 36(4):283-90. PubMed ID: 18455049
[TBL] [Abstract][Full Text] [Related]
23. Antimicrobial resistance profile of bacterial isolates from Intensive Care Unit: changing trends.
Anupurba S; Sen MR
J Commun Dis; 2005 Mar; 37(1):58-65. PubMed ID: 16637402
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit.
Archibald L; Phillips L; Monnet D; McGowan JE; Tenover F; Gaynes R
Clin Infect Dis; 1997 Feb; 24(2):211-5. PubMed ID: 9114149
[TBL] [Abstract][Full Text] [Related]
25. Efforts of pharmacy to reduce antibiotic resistance.
Klem C; Dasta JF
New Horiz; 1996 Aug; 4(3):377-84. PubMed ID: 8856756
[TBL] [Abstract][Full Text] [Related]
26. Antimicrobial resistance in nosocomial bloodstream infection associated with pneumonia and the value of systematic surveillance cultures in an adult intensive care unit.
Depuydt PO; Blot SI; Benoit DD; Claeys GW; Verschraegen GL; Vandewoude KH; Vogelaers DP; Decruyenaere JM; Colardyn FA
Crit Care Med; 2006 Mar; 34(3):653-9. PubMed ID: 16505649
[TBL] [Abstract][Full Text] [Related]
27. Adverse drug event reporting in intensive care units: a survey of current practices.
Kane-Gill SL; Devlin JW
Ann Pharmacother; 2006; 40(7-8):1267-73. PubMed ID: 16849619
[TBL] [Abstract][Full Text] [Related]
28. Intensive care unit drug utilization in a teaching hospital in Nepal.
Shankar PR; Partha P; Dubey AK; Mishra P; Deshpande VY
Kathmandu Univ Med J (KUMJ); 2005; 3(2):130-7. PubMed ID: 16415608
[TBL] [Abstract][Full Text] [Related]
29. Intensive care telemedicine: evaluating a model for proactive remote monitoring and intervention in the critical care setting.
Groves RH; Holcomb BW; Smith ML
Stud Health Technol Inform; 2008; 131():131-46. PubMed ID: 18305328
[TBL] [Abstract][Full Text] [Related]
30. [Glycopeptide-resistant Enterococcus outbreak in an ICU with simultaneous circulation of two different clones].
Delamare C; Lameloise V; Lozniewski A; Perrin M; Baudin C; Sellies J; Dumay M; Bemer M;
Pathol Biol (Paris); 2008; 56(7-8):454-60. PubMed ID: 18835105
[TBL] [Abstract][Full Text] [Related]
31. Structural and process factors affecting the implementation of antimicrobial resistance prevention and control strategies in U.S. hospitals.
Chou AF; Yano EM; McCoy KD; Willis DR; Doebbeling BN
Health Care Manage Rev; 2008; 33(4):308-22. PubMed ID: 18815496
[TBL] [Abstract][Full Text] [Related]
32. Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy.
Shorr AF; Combes A; Kollef MH; Chastre J
Crit Care Med; 2006 Mar; 34(3):700-6. PubMed ID: 16505656
[TBL] [Abstract][Full Text] [Related]
33. Development and validation of measures to assess prevention and control of AMR in hospitals.
Flanagan M; Ramanujam R; Sutherland J; Vaughn T; Diekema D; Doebbeling BN
Med Care; 2007 Jun; 45(6):537-44. PubMed ID: 17515781
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals.
Monnet DL; Archibald LK; Phillips L; Tenover FC; McGowan JE; Gaynes RP
Infect Control Hosp Epidemiol; 1998 Jun; 19(6):388-94. PubMed ID: 9669619
[TBL] [Abstract][Full Text] [Related]
35. Tele-ICU - a Canadian review.
Shahpori R; Kushniruk A; Hebert M; Zuege D
Stud Health Technol Inform; 2011; 164():420-4. PubMed ID: 21335747
[TBL] [Abstract][Full Text] [Related]
36. Drug resistant organisms and their implications for the outpatient dialysis setting.
Alexander D; Peacock E
Nephrol News Issues; 1997 Oct; 11(10):27-8, 30-1, 33-4. PubMed ID: 9391388
[TBL] [Abstract][Full Text] [Related]
37. Strategies for study of the role of cycling on antimicrobial use and resistance.
McGowan JE
Infect Control Hosp Epidemiol; 2000 Jan; 21(1 Suppl):S36-43. PubMed ID: 10654634
[TBL] [Abstract][Full Text] [Related]
38. Intensive care unit antimicrobial resistance and the role of the pharmacist.
Ibrahim KH; Gunderson B; Rotschafer JC
Crit Care Med; 2001 Apr; 29(4 Suppl):N108-13. PubMed ID: 11292885
[TBL] [Abstract][Full Text] [Related]
39. Antimicrobial resistance: an overview.
Solomkin JS
New Horiz; 1996 Aug; 4(3):319-20. PubMed ID: 8856748
[No Abstract] [Full Text] [Related]
40. Patterns of medical care in a municipal hospital. Intensive care unit: convenience or necessity?
Carroll DG
Md State Med J; 1971 Jan; 20(1):89-94. PubMed ID: 5141507
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
